Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors

Recently, there is considerable interest in the field of anti-HIV therapy to identify and develop chromatin-modifying histone deacetylase (HDAC) inhibitors that can effectively reactivate latent HIV in patients. The hope is that this would help eliminate cells harboring latent HIV and achieve an eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Gautam K, Cloyd, Miles W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168425/
https://www.ncbi.nlm.nih.gov/pubmed/21838863
http://dx.doi.org/10.1186/1743-422X-8-400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168425/
https://www.ncbi.nlm.nih.gov/pubmed/21838863
http://dx.doi.org/10.1186/1743-422X-8-400

Ejemplares similares